diallyl trisulfide has been researched along with Cirrhosis, Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, X; Liu, Q; Pang, H; Wang, C; Wang, L; Ye, J; Zhang, J; Zhou, X | 1 |
1 other study(ies) available for diallyl trisulfide and Cirrhosis, Liver
| Article | Year |
|---|---|
Diallyl trisulfide plays an antifibrotic role by inhibiting the expression of Bcl-2 in hepatic stellate cells.
Topics: Allyl Compounds; Apoptosis; bcl-2-Associated X Protein; Fibrosis; Hepatic Stellate Cells; Humans; Liver Cirrhosis; Sulfides | 2022 |